CARE vs BPRN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 22, 2026

CARE

54.5
AI Score
VS
CARE Wins

BPRN

51.6
AI Score

Investment Advisor Scores

CARE

55score
Recommendation
HOLD

BPRN

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE BPRN Winner
Forward P/E 13.6612 11.1982 BPRN
PEG Ratio 0 0 Tie
Revenue Growth 260.0% 3.8% CARE
Earnings Growth 900.8% 18.2% CARE
Tradestie Score 54.5/100 51.6/100 CARE
Profit Margin 41.8% 24.8% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: +6.9% · 3M: +36.9% BPRN 1M: +8.8% · 3M: +17.4%

Current Technical Phase

CARE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.5% over 20 days), RSI 70

RSI (14): 70.0 · Price: $35.43

BPRN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.6% over 20 days), RSI 70

RSI (14): 69.5 · Price: $42.40

Fundamentals Snapshot

Metric CARE BPRN
Market Cap
Forward P/E 13.8 11.1
Trailing P/E 6.0 10.9
Revenue (TTM)
Revenue Growth 0.7% 0.6%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.4%
EPS 5.80 3.78
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.